Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/14/2025

Risperidone Dosing Guidelines When Switching from Quetiapine

Introduction to Risperidone Dosing

  • The National Comprehensive Cancer Network (NCCN) guidelines recommend starting risperidone at 0.5-1 mg twice daily for delirium management, which aligns with general initiation principles 1, 2

Evidence-Based Dosing Strategy

  • The NCCN guidelines specifically recommend risperidone 0.5-1 mg twice daily as the standard starting dose, which is also the initial target dose 1, 2
  • International guidelines for early psychosis recommend 2 mg/day as the appropriate initial target dose for most patients with first-episode psychosis 3
  • For early psychosis, maximum doses should generally not exceed 4 mg/day risperidone, as this represents the upper limit before significant extrapyramidal side effects (EPS) risk increases 4

Monitoring and Precautions

  • Evaluate sleep patterns, since quetiapine's sedating properties may not be matched by risperidone 5
  • Monitor for orthostatic hypotension and dizziness, particularly in older adults during the transition period 6
  • Be cautious in elderly patients with dementia, as antipsychotics including risperidone carry increased mortality risk in this population 7

REFERENCES

1

nccn clinical practice guidelines in oncology: palliative care. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2009

2

nccn clinical practice guidelines in oncology: palliative care. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2009

5

Guidelines for Switching from Quetiapine to Tiapride [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

6

Hangover Effects of Quetiapine Formulations [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

7

Crushing Seroquel Formulations [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025